NCT03852797View on ClinicalTrials.gov

Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

January 19, 2022

Study Completion Date

January 19, 2022

Conditions

Postpartum Hemorrhage

Interventions

DRUG

Oxytocin

Oxytocin solution, 20nM concentration

DRUG

Ketamine

Ketamine in solution, 10-4M to 10-7M

DRUG

Propofol

Propofol in solution, 10-4M to 10-7M

DRUG

Etomidate

Etomidate in solution, 10-4M to 10-7M

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors

lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT03852797 - Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium | Biotech Hunter | Biotech Hunter